이민규 (Harvard Medical School)님 | 한빛사연구자 > 한빛사

Harvard Medical School

최종업데이트 2024.10.08.

- 이민규(Harvard Medical School)
Cysteinyl Leukotrienes in Allergic Inflammation
- Annu. Rev. Pathol.-Mech. Dis., Oct 07 2024, | https://doi.org/10.1146/annurev-pathmechdis-111523-023509
- 2024-10
- 의약학
- 한빛사논문
Protein stabilization of ITF2 by NF-κB prevents colitis-associated cancer development
- Nat. Commun., Published: 25 April 2023 | https://doi.org/10.1038/s41467-023-38080-w
- 2023-04
- 의약학
- 한빛사논문
DEP-induced ZEB2 promotes nasal polyp formation via epithelial-to-mesenchymal transition
- J. Allergy Clin. Immunol., Available online 4 May 2021 | https://doi.org/10.1016/j.jaci.2021.04.024
- 2021-05
- 의약학
- 한빛사논문
Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transition
- J. Allergy Clin. Immunol., Available online 2 September 2015 | doi:10.1016/j.jaci.2015.07.026
- 2015-09
- 의약학
- 한빛사논문

연구자 ID

저자논문